Trial intelligence / Profile preview

Renal Hemodynamics and Tubular Function in OSA

NCT00410085Phase 4Completed

Sponsor
Regionshospitalet Holstebro
Start
Jan 2005
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of NG-monomethyl-L-arginine in obstructive sleep apnea (OSA), sponsored by Regionshospitalet Holstebro. Started Jan 2005; status: completed.

02

Drugs

NG-monomethyl-L-arginine
03

Conditions

obstructive sleep apnea (OSA)

Beyond the preview

Go deeper on NCT00410085.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00410085.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call